BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 28640667)

  • 1. Restricting retrotransposons: ADAR1 is another guardian of the human genome.
    Orecchini E; Frassinelli L; Michienzi A
    RNA Biol; 2017 Nov; 14(11):1485-1491. PubMed ID: 28640667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAR1 restricts LINE-1 retrotransposition.
    Orecchini E; Doria M; Antonioni A; Galardi S; Ciafrè SA; Frassinelli L; Mancone C; Montaldo C; Tripodi M; Michienzi A
    Nucleic Acids Res; 2017 Jan; 45(1):155-168. PubMed ID: 27658966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RNA editing enzyme ADAR2 restricts L1 mobility.
    Frassinelli L; Orecchini E; Al-Wardat S; Tripodi M; Mancone C; Doria M; Galardi S; Ciafrè SA; Michienzi A
    RNA Biol; 2021 Oct; 18(sup1):75-87. PubMed ID: 34224323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.
    Mannion NM; Greenwood SM; Young R; Cox S; Brindle J; Read D; Nellåker C; Vesely C; Ponting CP; McLaughlin PJ; Jantsch MF; Dorin J; Adams IR; Scadden AD; Ohman M; Keegan LP; O'Connell MA
    Cell Rep; 2014 Nov; 9(4):1482-94. PubMed ID: 25456137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Aicardi-Goutières syndrome mutations predicted from ADAR-RNA structures.
    Fisher AJ; Beal PA
    RNA Biol; 2017 Feb; 14(2):164-170. PubMed ID: 27937139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine-to-inosine RNA editing in the immune system: friend or foe?
    Nakahama T; Kawahara Y
    Cell Mol Life Sci; 2020 Aug; 77(15):2931-2948. PubMed ID: 31996954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown.
    Chung H; Calis JJA; Wu X; Sun T; Yu Y; Sarbanes SL; Dao Thi VL; Shilvock AR; Hoffmann HH; Rosenberg BR; Rice CM
    Cell; 2018 Feb; 172(4):811-824.e14. PubMed ID: 29395325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aicardi-Goutières syndrome-associated mutation at ADAR1 gene locus activates innate immune response in mouse brain.
    Guo X; Wiley CA; Steinman RA; Sheng Y; Ji B; Wang J; Zhang L; Wang T; Zenatai M; Billiar TR; Wang Q
    J Neuroinflammation; 2021 Jul; 18(1):169. PubMed ID: 34332594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of RNA editing enzyme ADAR1 in human disease.
    Song B; Shiromoto Y; Minakuchi M; Nishikura K
    Wiley Interdiscip Rev RNA; 2022 Jan; 13(1):e1665. PubMed ID: 34105255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature.
    Rice GI; Kasher PR; Forte GM; Mannion NM; Greenwood SM; Szynkiewicz M; Dickerson JE; Bhaskar SS; Zampini M; Briggs TA; Jenkinson EM; Bacino CA; Battini R; Bertini E; Brogan PA; Brueton LA; Carpanelli M; De Laet C; de Lonlay P; del Toro M; Desguerre I; Fazzi E; Garcia-Cazorla A; Heiberg A; Kawaguchi M; Kumar R; Lin JP; Lourenco CM; Male AM; Marques W; Mignot C; Olivieri I; Orcesi S; Prabhakar P; Rasmussen M; Robinson RA; Rozenberg F; Schmidt JL; Steindl K; Tan TY; van der Merwe WG; Vanderver A; Vassallo G; Wakeling EL; Wassmer E; Whittaker E; Livingston JH; Lebon P; Suzuki T; McLaughlin PJ; Keegan LP; O'Connell MA; Lovell SC; Crow YJ
    Nat Genet; 2012 Nov; 44(11):1243-8. PubMed ID: 23001123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An I for an A: Dynamic Regulation of Adenosine Deamination-Mediated RNA Editing.
    Vesely C; Jantsch MF
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the adenosine deaminase ADAR1 that prevent endogenous Z-RNA binding induce Aicardi-Goutières-syndrome-like encephalopathy.
    Nakahama T; Kato Y; Shibuya T; Inoue M; Kim JI; Vongpipatana T; Todo H; Xing Y; Kawahara Y
    Immunity; 2021 Sep; 54(9):1976-1988.e7. PubMed ID: 34525338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA-editing enzymes ADAR1 and ADAR2 coordinately regulate the editing and expression of Ctn RNA.
    Anantharaman A; Gholamalamdari O; Khan A; Yoon JH; Jantsch MF; Hartner JC; Gorospe M; Prasanth SG; Prasanth KV
    FEBS Lett; 2017 Sep; 591(18):2890-2904. PubMed ID: 28833069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive ADAR editing reporter in cancer cells enables high-throughput screening of small molecule libraries.
    Fritzell K; Xu LD; Otrocka M; Andréasson C; Öhman M
    Nucleic Acids Res; 2019 Feb; 47(4):e22. PubMed ID: 30590609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation.
    de Reuver R; Verdonck S; Dierick E; Nemegeer J; Hessmann E; Ahmad S; Jans M; Blancke G; Van Nieuwerburgh F; Botzki A; Vereecke L; van Loo G; Declercq W; Hur S; Vandenabeele P; Maelfait J
    Nature; 2022 Jul; 607(7920):784-789. PubMed ID: 35859175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine-to-inosine editing of endogenous Z-form RNA by the deaminase ADAR1 prevents spontaneous MAVS-dependent type I interferon responses.
    Tang Q; Rigby RE; Young GR; Hvidt AK; Davis T; Tan TK; Bridgeman A; Townsend AR; Kassiotis G; Rehwinkel J
    Immunity; 2021 Sep; 54(9):1961-1975.e5. PubMed ID: 34525337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing of
    Shiromoto Y; Sakurai M; Qu H; Kossenkov AV; Nishikura K
    RNA; 2020 Dec; 26(12):1801-1814. PubMed ID: 32817447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAR1 interaction with Z-RNA promotes editing of endogenous double-stranded RNA and prevents MDA5-dependent immune activation.
    de Reuver R; Dierick E; Wiernicki B; Staes K; Seys L; De Meester E; Muyldermans T; Botzki A; Lambrecht BN; Van Nieuwerburgh F; Vandenabeele P; Maelfait J
    Cell Rep; 2021 Aug; 36(6):109500. PubMed ID: 34380029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editor meets silencer: crosstalk between RNA editing and RNA interference.
    Nishikura K
    Nat Rev Mol Cell Biol; 2006 Dec; 7(12):919-31. PubMed ID: 17139332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine-to-inosine Alu RNA editing controls the stability of the pro-inflammatory long noncoding RNA NEAT1 in atherosclerotic cardiovascular disease.
    Vlachogiannis NI; Sachse M; Georgiopoulos G; Zormpas E; Bampatsias D; Delialis D; Bonini F; Galyfos G; Sigala F; Stamatelopoulos K; Gatsiou A; Stellos K
    J Mol Cell Cardiol; 2021 Nov; 160():111-120. PubMed ID: 34302813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.